HOUSTON — In a groundbreaking move, the FDA has approved the second phase of clinical trials for the BiVACOR mechanical heart, a device that could potentially make human heart transplants a thing of ...
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to BiVACOR’s total artificial heart (BTAH), greenlighting the way for an early feasibility study in ...
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Raymond W. Cohen has been ...
The Texas Heart Institute in the US has successfully implanted BiVACOR’s total artificial heart (BTAH) inside a human being. The first patient – a 57-year-old man with end-stage heart failure – was ...
The BiVACOR Total Artificial Heart (TAH) is a compact, titanium-constructed device about the size of a fist. Despite its small stature, it packs a powerful punch. It can pump blood at a rate of 12 ...
CINCINNATI (WKRC) — A groundbreaking artificial heart technology has saved the life of Michael Herrmann, one of the few patients worldwide to benefit from this innovation while awaiting a heart ...
HUNTINGTON BEACH, Calif. & GOLD COAST, Australia & HOUSTON--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical device company developing a total artificial heart (TAH), today announced the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Bivacor is also gearing up for ...
On a scale of cardiac density that begins with Blondie’s heart of glass and ends with the Rolling Stones’ heart of stone, Houston-based startup Bivacor’s artificial ticker falls somewhere in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results